Baxter Life2000 Ventilator Recall Issued Over Battery Charging Problems Linked To Patient Injury

Failures of the Life2000 Ventilator battery charging dongle may cause serious or fatal injuries for patients receiving life-sustaining oxygen.

Federal regulators say a problem with the Baxter Life2000 ventilator may result in the devices failing to charge, and thus failing to provide life-sustaining oxygen to patients, which could put them at risk of sustaining serious injury or death.

The U.S. Food and Drug Administration (FDA) announced the Baxter Life2000 ventilator recall on July 15, indicating that the battery charging dongle may fail. The agency has given it a Class I recall designation, which is the most serious recall classification the agency can assign to a medical device.

The Life2000 is a portable ventilation device designed to provide respiratory support to patients who require mechanical ventilation. To use the device, the caregiver or patient first ensures it is properly charged or connected to a power source. It is then set up according to the prescribed settings, which may include adjusting the airflow, pressure, and timing based on the patient’s specific needs.

For non-invasive ventilation, a mask or nasal cannula is fitted to the patient, while invasive ventilation requires a connection to a tracheostomy tube. The device continuously monitors the patient’s respiratory status and provides real-time feedback and alarms to ensure optimal operation.

Due to the battery charging dongle problems, the device may fail to charge properly. A charging failure means a patient will not be able to use the ventilator properly, which could result in oxygen desaturation episodes that range from mild to potentially life-threatening. At least one injury has already been linked to the problem.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

The recall affects about 2,500 Life200 Ventilator Systems, with product codes BT-20-0002, BT-20-0002A and BT-20-0002AP.

Baxter originally announced the recall to its customers through a May 29 Urgent Medical Device Recall letter. It recommended customers check the ventilator battery for the charge icon while it is plugged into the charging dongle, observe any alarms given off by the devices, and to review the device’s quick reference guide for details about the battery charge and associated alarms.

If customers find they have a unit that fails to charge as expected, or have questions about the recall, they should immediately contact Baxter Acute Care Customer Service Support at 800-426-4224- and choose option 2 to obtain a replacement, the letter stated.

Healthcare professionals and consumers can report adverse reactions or quality issues experienced with these devices to MedWatch, the FDA Safety Information and Adverse Event Reporting Program.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month
Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month (Posted today)

Parties have been directed to meet quarterly for mediation sessions, which will explore the potential for Tepezza hearing loss settlements, as the talks leading up to the first bellwether trials, slated to begin in March 2026.

Judge Allows New Ozempic, Wegovy Lawsuits To Be Directly Filed in Federal MDL
Judge Allows New Ozempic, Wegovy Lawsuits To Be Directly Filed in Federal MDL (Posted yesterday)

A federal judge is allowing those presenting Ozempic, Wegovy and Mounjaro lawsuits to file them directly with the MDL court to speed up the process of preparing the cases for potential future bellwether trials.

More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug
More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug (Posted 2 days ago)

Plaintiffs and defendants have briefed the new incoming judge on the status of more than 1,200 Valsartan lawsuits ahead of a meeting later this month, which seeks to begin moving the litigation forward following the retirement of the preceding presiding judge.